You Zhi Tong
Directeur Général chez KINTOR PHARMACEUTICAL LIMITED
Fortune : 6 M $ au 31/05/2024
Postes actifs de You Zhi Tong
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KINTOR PHARMACEUTICAL LIMITED | Directeur Général | 24/03/2009 | - |
| Président | 24/03/2009 | - | |
| Fondateur | 24/03/2009 | - | |
Suzhou Kintor Pharmaceuticals, Inc.
 Suzhou Kintor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Suzhou Kintor Pharmaceuticals, Inc. engages in the technology research and development, technical services, transfer, and advice of drugs and reagents. The company was founded by Youzhi Tong on March 24, 2009 and is headquartered in Suzhou, China. | Directeur Général | - | - |
| Président | - | - | |
| Fondateur | 24/03/2009 | - |
Historique de carrière de You Zhi Tong
Anciens postes connus de You Zhi Tong
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ANGN BIOM | Corporate Officer/Principal | - | - |
Formation de You Zhi Tong
| Cornell University | Doctorate Degree |
| Peking University | Graduate Degree |
Statistiques
Internationale
| Chine | 4 |
| Etats-Unis | 3 |
Opérationnelle
| Chief Executive Officer | 2 |
| Chairman | 2 |
| Founder | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KINTOR PHARMACEUTICAL LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Suzhou Kintor Pharmaceuticals, Inc.
Suzhou Kintor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Suzhou Kintor Pharmaceuticals, Inc. engages in the technology research and development, technical services, transfer, and advice of drugs and reagents. The company was founded by Youzhi Tong on March 24, 2009 and is headquartered in Suzhou, China. | Health Technology |
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
- Bourse
- Insiders
- You Zhi Tong
- Expérience
